These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34689083)

  • 1. Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
    Ashton TD; Ngo A; Favuzza P; Bullen HE; Gancheva MR; Romeo O; Parkyn Schneider M; Nguyen N; Steel RWJ; Duffy S; Lowes KN; Sabroux HJ; Avery VM; Boddey JA; Wilson DW; Cowman AF; Gilson PR; Sleebs BE
    Bioorg Chem; 2021 Dec; 117():105359. PubMed ID: 34689083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity.
    Gilson PR; Tan C; Jarman KE; Lowes KN; Curtis JM; Nguyen W; Di Rago AE; Bullen HE; Prinz B; Duffy S; Baell JB; Hutton CA; Jousset Subroux H; Crabb BS; Avery VM; Cowman AF; Sleebs BE
    J Med Chem; 2017 Feb; 60(3):1171-1188. PubMed ID: 28080063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 4-Amino 2-Anilinoquinazolines against
    Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
    Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
    Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957.
    Miguel-Blanco C; Murithi JM; Benavente ED; Angrisano F; Sala KA; van Schalkwyk DA; Vanaerschot M; Schwach F; Fuchter MJ; Billker O; Sutherland CJ; Campino SG; Clark TG; Blagborough AM; Fidock DA; Herreros E; Gamo FJ; Baum J; Delves MJ
    Sci Rep; 2021 Jan; 11(1):1888. PubMed ID: 33479319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
    Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
    Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
    Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity.
    Bailey BL; Nguyen W; Ngo A; Goodman CD; Gancheva MR; Favuzza P; Sanz LM; Gamo FJ; Lowes KN; McFadden GI; Wilson DW; Laleu B; Brand S; Jackson PF; Cowman AF; Sleebs BE
    Bioorg Chem; 2021 Oct; 115():105244. PubMed ID: 34452759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite.
    Hirai S; Kikuchi H; Kim HS; Begum K; Wataya Y; Tasaka H; Miyazawa Y; Yamamoto K; Oshima Y
    J Med Chem; 2003 Sep; 46(20):4351-9. PubMed ID: 13678413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
    Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
    J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Plasmodium falciparum Inhibitory Activity, Cytotoxicity and Solubility of N2 ,N4 -Disubstituted Quinazoline-2,4-diamines.
    Pobsuk N; Suphakun P; Hannongbua S; Nantasenamat C; Choowongkomon K; Gleeson MP
    Med Chem; 2019; 15(6):693-704. PubMed ID: 30569870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of a new type of antimalarial compounds based on febrifugine.
    Kikuchi H; Yamamoto K; Horoiwa S; Hirai S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
    J Med Chem; 2006 Jul; 49(15):4698-706. PubMed ID: 16854076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents.
    Zhu S; Zhang Q; Gudise C; Wei L; Smith E; Zeng Y
    Bioorg Med Chem; 2009 Jul; 17(13):4496-502. PubMed ID: 19467876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel quinazoline derivatives as potent antiplasmodial agents.
    Bouchut A; Rotili D; Pierrot C; Valente S; Lafitte S; Schultz J; Hoglund U; Mazzone R; Lucidi A; Fabrizi G; Pechalrieu D; Arimondo PB; Skinner-Adams TS; Chua MJ; Andrews KT; Mai A; Khalife J
    Eur J Med Chem; 2019 Jan; 161():277-291. PubMed ID: 30366254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
    Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines.
    Delarue S; Girault S; Maes L; Debreu-Fontaine MA; Labaeïd M; Grellier P; Sergheraert C
    J Med Chem; 2001 Aug; 44(17):2827-33. PubMed ID: 11495593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.